logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Takayuki Takeda

japanese red cross kyoto daini hospital
H指数:22
被引数:2,736

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of Hidden Cachexia Subgroup in PD-L1-High NSCLC: Comparative Analysis of the AWGC vs. Fearon Criteria

识别PD-L1高表达非小细胞肺癌中隐藏恶病质亚组：AWGC与Fearon标准的比较分析

journal of cachexia, sarcopenia and muscle
IF0
2026-04-120
OAAI
Naoya Nishioka; Hayato Kawachi; Tadaaki Yamada; Motohiro Tamiya; Yoshiki Negi; Yasuhiro Goto; Akira Nakao; Shinsuke Shiotsu; Keiko Tanimura; Takayuki Takeda; Asuka Okada; Taishi Harada; Koji Date; Yusuke Chihara; Isao Hasegawa; Nobuyo Tamiya; Takeo Ogawa; Masahiro Iwasaku; Shinsaku Tokuda; Takashi Kijima; Koichi Takayama
Selecting optimal immunotherapy based on inflammation in stage IV PD-L1 ≥50% gene mutation-negative non-small cell lung cancer: pembrolizumab monotherapy versus combination chemoimmunotherapy

基于炎症选择最优免疫疗法：用于PD-L1 ≥50%基因突变阴性IV期非小细胞肺癌：帕博利珠单抗单药治疗与联合化疗免疫疗法

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2025-11-300
PRE
Kunimatsu, Yusuke; Nishioka, Naoya; Yamada, Tadaaki; Kawachi, Hayato; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Ishida, Masaki; Kijima, Takashi; Takayama, Koichi
Impact of the Lung Immune Prognostic Index in non-small-cell lung cancer patients with PD-L1-low/negative tumors receiving chemoimmunotherapy: a real-world multicenter retrospective study

肺癌免疫预后指数在PD-L1低表达/阴性肿瘤的非小细胞肺癌患者接受化疗免疫治疗中的影响：一项真实世界多中心回顾性研究

ESMO Open
IF8.3
2025-11-200
OAAI
A. Yoshimura; T. Takeda; K. Tanimura; Y. Chihara; H. Kawachi; Y. Yamanaka; N. Tamiya; R. Honda; T. Yamada; K. Uryu; S. Shiotsu; H. Yoshioka; T. Yamada; T. Kurata; K. Takayama
Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy
ONCOIMMUNOLOGY
IF6.3
2024-12-160
OAAI
Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Kijima, Takashi; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Shimose, Takayuki; Takayama, Koichi
CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study
TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2024-08-010
OAAI
Kataoka, Nobutaka; Katayama, Yuki; Yamada, Tadaaki; Morimoto, Kenji; Takeda, Takayuki; Okada, Asuka; Shiotsu, Shinsuke; Chihara, Yusuke; Yamada, Takahiro; Hiranuma, Osamu; Ota, Takahiro; Harada, Taishi; Hasegawa, Isao; Nishioka, Naoya; Iwasaku, Masahiro; Tokuda, Shinsaku; Takayama, Koichi
Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study
FRONTIERS IN IMMUNOLOGY
IF5.9
2024-07-150
OAAI
Nishioka, Naoya; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Masui, Taiki; Sai, Natsuki; Ishida, Masaki; Katayama, Yuki; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)
TARGETED ONCOLOGY
IF4
2024-04-133
OAAI
Nishioka, Naoya; Imai, Hisao; Endo, Masahiro; Notsu, Akifumi; Doshita, Kosei; Igawa, Satoshi; Yokouchi, Hiroshi; Ninomiya, Takashi; Tokito, Takaaki; Soda, Sayo; Fujiwara, Takasato; Asao, Tetsuhiko; Nakamichi, Shinji; Kawamura, Takahisa; Inomata, Minehiko; Nakashima, Kazuhisa; Ito, Kentaro; Goto, Yasuhiro; Umeda, Yukihiro; Hirai, Soichi; Ushio, Ryota; Yokoo, Keiki; Takeda, Takayuki; Fukui, Tomoya; Ishihara, Masashi; Osaki, Takashi; Kubo, Sousuke; Fujiwara, Takumi; Yamamoto, Chie; Tsuda, Takeshi; Tamura, Nobumasa; Hosokawa, Shinobu; Chihara, Yusuke; Ikeda, Satoshi; Furuya, Naoki; Nakahara, Yoshiro; Miura, Satoru; Okamoto, Hiroaki
Association between clinical characteristics and treatment outcome of immune checkpoint inhibitor with or without chemotherapy in elderly non-small cell lung cancer patients with high PD-L1 expression
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Kawachi, Hayato; Takei, Shota; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Kijima, Takashi; Takayama, Koichi
Comparing Three Different Anti-Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2024-03-010
OA
Katayama, Yuki; Yamada, Tadaaki; Morimoto, Kenji; Fujii, Hiroyuki; Morita, Satomi; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Shiotsu, Shinsuke; Chihara, Yusuke; Hiranuma, Osamu; Yamada, Takahiro; Ota, Takahiro; Harada, Taishi; Hasegawa, Isao; Iwasaku, Masahiro; Tokuda, Shinsaku; Tanaka, Noriyuki; Miyagawa-Hayashino, Aya; Takayama, Koichi
Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50%

免疫检查点抑制剂联合化疗对TPS ≥ 50% 的老年非小细胞肺癌PD-L1预后的影响

FRONTIERS IN IMMUNOLOGY
IF5.9
2024-02-232
OAAI
Takei, Shota; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi
Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study
FRONTIERS IN ONCOLOGY
IF3.3
2024-01-260
OAAI
Yoshimura, Akihiro; Takeda, Takayuki; Kataoka, Nobutaka; Tanimura, Keiko; Fukui, Mototaka; Chihara, Yusuke; Takei, Shota; Kawachi, Hayato; Nakanishi, Kentaro; Yamanaka, Yuta; Tamiya, Nobuyo; Honda, Ryoichi; Okura, Naoko; Yamada, Takahiro; Uryu, Kiyoaki; Murai, Junji; Shiotsu, Shinsuke; Yoshioka, Hiroshige; Yamada, Tadaaki; Kurata, Takayasu; Takayama, Koichi
Chemoimmunotherapy Versus Pembrolizumab as a First-Line Treatment for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Focus on the Role of Performance Status
TARGETED ONCOLOGY
IF4
2023-10-302
PRE
Morimoto, Kenji; Yamada, Tadaaki; Kawachi, Hayato; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Nishioka, Naoya; Katayama, Yuki; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi
Clinical impact of proton pump inhibitor on the therapeutic outcome of non-small cell lung cancer patients with PD-L1 TPS I50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor plus chemotherapy: A retrospective multicenter cohort study
ANNALS OF ONCOLOGY
IF65.4
2023-10-010
OA
Kawachi, H.; Yamada, T.; Tamiya, M.; Negi, Y.; Goto, Y.; Nakao, A.; Shiotsu, S.; Tanimura, K.; Takeda, T.; Okada, A.; Harada, T.; Date, K.; Chihara, Y.; Hasegawa, I.; Tamiya, N.; Iwasaku, M.; Tokuda, S.; Kijima, T.; Takayama, K.
Prospective Observational Study Evaluating the Prognostic Value of the G8 Screening Tool for Extensive-Stage Small Cell Lung Cancer Patients Who Received Programmed Death-Ligand 1 Inhibitor plus Platinum-Etoposide Chemotherapy
DRUGS & AGING
IF3.8
2023-05-055
PRE
Morimoto, Kenji; Yamada, Tadaaki; Takeda, Takayuki; Shiotsu, Shinsuke; Date, Koji; Harada, Taishi; Tamiya, Nobuyo; Chihara, Yusuke; Takemura, Yoshizumi; Yamada, Takahiro; Kanda, Hibiki; Ishida, Masaki; Yoshimura, Akihiro; Iwasaku, Masahiro; Tokuda, Shinsaku; Kim, Young Hak; Takayama, Koichi
TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-04-015
OA
Katayama, Yuki; Yamada, Tadaaki; Morimoto, Kenji; Fujii, Hiroyuki; Morita, Satomi; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Shiotsu, Shinsuke; Chihara, Yusuke; Hiranuma, Osamu; Yamada, Takahiro; Ota, Takahiro; Harada, Taishi; Hasegawa, Isao; Yoshimura, Akihiro; Iwasaku, Masahiro; Tokuda, Shinsaku; Kim, Young Hak; Takayama, Koichi
Early Tumor Shrinkage as a Predictor of Favorable Treatment Outcomes in Patients With Extensive- Stage SCLC Who Received Programmed Cell Death- Ligand 1 Inhibitor Plus Platinum-Etoposide Chemotherapy: A Prospective Observational Study
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-04-013
OA
Ishida, Masaki; Morimoto, Kenji; Yamada, Tadaaki; Takeda, Takayuki; Shiotsu, Shinsuke; Date, Koji; Harada, Taishi; Tamiya, Nobuyo; Chihara, Yusuke; Takemura, Yoshizumi; Yamada, Takahiro; Kanda, Hibiki; Iwasaku, Masahiro; Tokuda, Shinsaku; Kim, Young Hak; Takayama, Koichi

研究方向

暂未获取到该数据
K
Koichi Takayama
H 指数:75论文数:954被引数:1.9万
T
Tadaaki Yamada
H 指数:41论文数:563被引数:6,294
Y
Yusuke Chihara
H 指数:23论文数:157被引数:3,151
S
Shinsuke Shiotsu
H 指数:17论文数:121被引数:1,392
M
Masahiro Iwasaku
H 指数:24论文数:135被引数:1,896
Y
Yasuhiro Gotô
H 指数:31论文数:334被引数:3,796
T
Taishi Harada
H 指数:32论文数:221被引数:3,854
K
Kenji Morimoto
H 指数:27论文数:222被引数:4,298
K
Keiko Tanimura
H 指数:13论文数:107被引数:1,061
S
Shinsaku Tokuda
H 指数:19论文数:120被引数:1,579